Interaction Check

This page cannot be displayed because your browser has been configured to disable JavaScript, also known as "Active Scripting".Please change your settings and refresh the page.

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

MultiCheck Results - 5 Interactions

Avoid/Use Alternative
Benlysta (belimumab) + Cyltezo (adalimumab-adbm) (adalimumab)
Avoid/Use Alternative belimumab + adalimumab avoid combo: combo may incr. risk of serious infection (additive effects)
Monitor/Modify Tx
Cyltezo (adalimumab-adbm) (adalimumab) + Tradjenta (linagliptin)
Monitor/Modify Tx adalimumab + linagliptin monitor cardiac fxn: combo may incr. risk of cardiotoxicity (additive effects)
Kenalog-40 (triamcinolone acetonide) + Tradjenta (linagliptin)
Monitor/Modify Tx triamcinolone + linagliptin monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)
Caution Advised
Benlysta (belimumab) + Kenalog-40 (triamcinolone acetonide)
Caution Advised belimumab + triamcinolone caution advised: combo may incr. risk of serious infection (additive effects)
Cyltezo (adalimumab-adbm) (adalimumab) + Kenalog-40 (triamcinolone acetonide)
Caution Advised adalimumab + triamcinolone caution advised: combo may incr. risk of serious infection (additive effects)
Additional Considerations
adalimumab in Cyltezo (adalimumab-adbm)
caution advised with narrow therapeutic index drugs; chronic inflammatory conditions may alter metabolic enzyme formation; tx with immune modulators may reverse this effect, resulting in altered levels of concomitant drugs